DCOY
Decoy Therapeutics Inc.
+0.10 (+3.46%)2.99USD4.7K成交股數2.0M市值0.0本益比(近四季)8.6股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 228K | – | – | 0 | – | – | – | – | – | – | – | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.3M | 750K | 62K | 116K | 76K | 175K | 137K | 214K | 243K | 1.0M | 2.4M | 3.7M |
| 銷售管理費用 | 1.3M | 1.5M | 833K | 849K | 1.6M | 1.3M | 869K | 1.3M | 1.5M | 1.5M | 1.6M | 1.7M |
| 營業利益 | −2.6M+53% | −2.3M+53% | −895K-11% | −966K-34% | −1.7M-3% | −1.5M-41% | −1.0M-75% | −1.5M-73% | −1.8M | −2.5M | −4.0M | −5.4M |
| 營業利益率 | -1,155.8% | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −2.4M+39% | −2.2M-123% | −873K-10% | −958K-33% | −1.7M-0% | 9.7M-497% | −972K-75% | −1.4M-73% | −1.7M | −2.4M | −3.9M | −5.3M |
| 淨利率 | -1,042.8% | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -4.46-98% | -4.18-92% | -1.81-84% | -81.21+3327% | -240.07+7242% | -52.52+908% | -11.38-1% | -2.37+6% | -3.27 | -5.21 | -11.45 | -2.23 |
| 稀釋股數 | 532K | 532K | 482K | 11.8K | 7.1K | 80.2K | 85.5K | 600K | 524K | 469K | 339K | 2.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 8.3M | 7.8M | 4.8M | 795K | 1.8M | 2.4M | 3.3M | 3.3M | 4.4M | 7.6M | 11.5M | 9.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 9.0M | 8.4M | 6.1M | 1.4M | 2.3M | 3.0M | 3.9M | 3.6M | 4.9M | 8.4M | 12.1M | 10.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.7M | 4.5M | 1.8M | 2.2M | 2.3M | 1.5M | 935K | 1.2M | 1.2M | 2.3M | 3.6M | 4.5M |
| 股東權益 | 4.3M | 3.9M | 4.2M | −830K | 62K | 1.5M | 2.9M | 2.4M | 3.6M | 6.1M | 8.4M | 5.6M |
| 負債比 | 52.0% | 54.0% | 30.3% | 159.6% | 97.4% | 50.0% | 24.2% | 33.2% | 25.3% | 27.6% | 30.2% | 44.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.9M | – | – | −1.2M-13% | – | – | – | −1.4M | – | – | −3.2M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 6K | – | – | 1K | – | – | – | 1K | – | – | 2K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2018 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2018 年度 · 838K
| Consumer Operations | 838K | 100.0% | -34.2% |
|---|
產品／服務2018 年度 · 2.8M
| Grant | 2.0M | 70.0% | +5.4% |
|---|---|---|---|
| 產品 | 827K | 29.6% | -34.5% |
| Product And Service Other | 12K | 0.4% | -14.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | 12.5M | –% | -129.10 | −5.4M |
| FY2024 | – | – | 5.6M | –% | -69.54 | −4.5M |
| FY2023 | – | – | 12.5M | –% | -30.74 | – |
| FY2022 | 0 | -100.0% | −31.6M | –% | -14.88 | – |
| FY2021 | 1.8M | -64.8% | −12.8M | -693.8% | -7.72 | −10.2M |
| FY2020 | 5.2M | +51.0% | −7.4M | -140.5% | -0.50 | −10.3M |
| FY2019 | 3.5M | +77.6% | −6.9M | -200.2% | -2.12 | −11.6M |
| FY2018 | 2.0M | – | −1.7M | -85.6% | -1.16 | 4.2M |